Nevirapine

This classification denotes a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 99DK7FVK1H. European Medicines Agency schedules Nevirapine, anhydrous in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25191. Nevirapine generally arises in the molecular formula C15H14N4O. The term NEVIRAPINE is a European Pharmacopoeia designation. NEVIRAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nevirapine under HS 29339940 and SITC 51577. As of Q4 2014, NEVIRAPINE remains the US FDA Preferred Term for this commodity. Nevirapine bears US NLM identifiers UMLS ID C0132326 and NCI Concept Code C29277. SMILES: O=C1[NH]C2C(N(C3CC3)C3NCCCC13)NCCC2C.